Trial site
Comprehensive Cancer Centers of Nevada
- 148running trials
- 56closed trials
The trials here
What the 211 trials at this site are about, from their registry records.
- Conditions
- Lung cancer44 trials
- Childhood cancers26 trials
- Colorectal cancer25 trials
- Prostate cancer22 trials
- Ovarian cancer17 trials
- Metastatic breast cancer16 trials
- Pancreatic cancer16 trials
- Bladder cancer14 trials
- Melanoma14 trials
- Gastric and oesophageal cancer13 trials
- Head and neck cancer12 trials
- Multiple myeloma11 trials
- and 27 more
- Phase
- Phase 389 trials
- Phase 266 trials
- Phase 2/315 trials
- Phase 114 trials
- Phase 1/212 trials
- Status
- Active, not recruiting111 trials
- Completed46 trials
- Recruiting35 trials
- Terminated9 trials
- Suspended7 trials
- Not yet recruiting2 trials
- Withdrawn1 trial
- Lead sponsor
- National Cancer Institute (NCI)66 trials
- SWOG Cancer Research Network23 trials
- Alliance for Clinical Trials in Oncology13 trials
- ECOG-ACRIN Cancer Research Group13 trials
- NRG Oncology10 trials
- and 59 more
Running trials
Recruiting
Recruiting
Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies
Recruiting
Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
Recruiting
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
Recruiting
Evaluation of RBS2418 in Patients With Advanced, Metastatic, and Progressive Colorectal Cancer
Recruiting
Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Safety/Efficacy Study of CID-078 in Patients With Advanced Solid Tumor Malignancies
Active, not recruiting
Recruiting
Ordastobart (INBRX-106) Add-on to Pembrolizumab in 1L HPV+ PD-L1+ R/M OPSCC (HexAgon-HN)
Recruiting
Cost Communication and Financial Navigation in Cancer Patients (COSTCOM)
Active, not recruiting
First-in-Human Study of OKI-219 in Advanced Solid Tumors and Advanced Breast Cancer
Recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
Recruiting
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Recruiting
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
Recruiting
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
Active, not recruiting
Active, not recruiting
Recruiting
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Active, not recruiting
Testing Nivolumab and Ipilimumab With Short-Course Radiation in Locally Advanced Rectal Cancer
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Showing 50 of 148.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Colorectal cancer6 recruiting
- Lung cancer5 recruiting
- Ovarian cancer5 recruiting
- Childhood cancers4 recruiting
- Gastric and oesophageal cancer4 recruiting
- Metastatic breast cancer4 recruiting
- Pancreatic cancer4 recruiting
- Bladder cancer3 recruiting
- Chronic lymphocytic leukaemia3 recruiting
- Multiple myeloma3 recruiting
- Triple-negative breast cancer3 recruiting
- Head and neck cancer2 recruiting
- Kidney cancer2 recruiting
- Melanoma2 recruiting
- Prostate cancer2 recruiting
- Acute lymphoblastic leukaemia1 recruiting
- Acute myeloid leukaemia1 recruiting
- Brain metastases1 recruiting
- Cervical cancer1 recruiting
- Chronic myeloid leukaemia1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Endometrial cancer1 recruiting
- Follicular lymphoma1 recruiting
- Mantle cell lymphoma1 recruiting
- Meningioma1 recruiting
- Mesothelioma1 recruiting
- Neuroendocrine tumours1 recruiting
- Sarcoma1 recruiting
Closed trials
Completed
Terminated
Activity and Safety of Danvatirsen and Pembrolizumab in HNSCC
Recruiting
A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer
Terminated
A Study of Modakafusp Alfa in Adult Participants With Multiple Myeloma
Recruiting
Completed
Completed
Terminated
Trilaciclib in Patients Receiving Sacituzumab Govitecan-hziy for Triple Negative Breast Cancer
Completed
Terminated
Efficacy Evaluation of Enobosarm Monotherapy in Treatment of AR+/ER+/HER2- Metastatic Breast Cancer
Completed
Terminated
Dose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid Tumors
Completed
Completed
Completed
Terminated
Completed
Completed
Completed
Completed
CASCARA: Castration Sensitive Carboplatin, Cabazitaxel and Abiraterone
Terminated
Completed
A Study of Tepotinib Plus Osimertinib in Osimertinib Relapsed MET Amplified NSCLC (INSIGHT 2)
Completed
Completed
Completed
Terminated
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
A Study of BMS-986253 in Combination With Nivolumab or Nivolumab Plus Ipilimumab in Advanced Cancers
Completed
Cancer Care Delivery in Adolescent and Young Adult Patients With Acute Lymphoblastic Leukemia
Completed
Completed
Completed
Completed
Completed
Completed
Atezolizumab in Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder Cancer
Completed
Completed
A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101)
Completed
Completed
Completed
Completed
Completed
S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer
Completed
Showing 50 of 56.
Site data: ClinicalTrials.govUpdated 18 Nov 2026